Delivery Order SPE2DB22D2206-SPE2DB25FDR14

Award Date 10/7/24
Potential Completion Date 10/29/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $17,368.14 contract is for the provision of WELIREG 40 MG TABLET 90S, a prescription pharmaceutical product, with a completion date of February 27, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is a global pharmaceutical sourcing and distribution services company that has received numerous...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,968.39, is for the supply of WELIREG 40 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,968.39 firm fixed-price contract is for the supply of WELIREG 40 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of March 12, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $17,368.14 to Amerisourcebergen Drug Corp for the supply of 4564762847 WELIREG 40 MG TABLET 90S. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,968.39 firm fixed-price delivery order contract is for the supply of WELIREG 40 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 25, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,968.39 Firm Fixed Price delivery order contract is for the supply of 4566639750 - WELIREG 40 MG TABLET 90S, with a period of performance through December 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,936.78 firm-fixed-price delivery order is for the supply of 4567409311 WELIREG 40 MG TABLET 90S, with a period of performance through March 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $17,968.39 and a completion date of January 6, 2025. It is a delivery order contract for the supply of WELIREG 40 MG TABLET 90S, a pharmaceutical product. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of pharmaceutical products, including the drug WELIREG 40 MG TABLET 90S. The contract has a ceiling value of $17,968.39 and a completion date of February 26, 2025. It is a firm fixed-price contract and is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a significant...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FA7B1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,968.39 firm fixed-price delivery order is for the supply of WELIREG 40 MG TABLET 90S, a pharmaceutical product, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FDR14
    Delivery Order

This is a $17,368.14 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4566043941 WELIREG 40 MG TABLET 90S. The contract does not have a set-aside designation and has an ultimate completion date of October 29, 2024.

AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under an Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This contract vehicle enables DLA to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals and medical supplies, to support military treatment programs and federal healthcare providers nationwide.

Generated 1/6/25, 12:33 PM